Among them, obeticholic acid, a bile acid derivative that activates the farnesoid X receptor displayed optimistic results in a study by Mudaliar et al.; it increased insulin sensitivity and reduced markers of liver fibrosis and inflammation in patients with NAFLD andT2DM [97]. This evidence concerns the gene INS and Hepatic fibrosis.